Highlights
- 1
Publications
21 publications
Funding
7 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- Co-IUM1AI164559-04HOPE - HIV Obstruction by Programmed EpigeneticsNational Institute of Allergy and Infectious Diseases · 2021–2027 · via University of California, San Francisco
- PISRA 214557-01Vironance Antiviral EfficiencyPlusSmarte Danmark ApS · 2021–2026Contract
Completed grants (5)
- Co-IR01CA260691-01Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaNational Cancer Institute · 2021–2024
- PIR21AI152929-02Expression of CircRNAs in HIV infection and latencyNational Institute of Allergy and Infectious Diseases · 2020–2023
- Co-IUM1AI126617-03BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral EradicationNational Institute of Allergy and Infectious Diseases · 2018–2023
- Co-IR01CA206488-03HIV induced anti-cancer HERV immunity in prostate, breast and colon cancersNational Cancer Institute · 2018–2022
- Co-IR01AI076059-11Elimination of HIV using HERV specific T cellsNational Institute of Allergy and Infectious Diseases · 2018–2020